News & Views

Feeling stressed? It might be your T cells

Abolishing signals mediated by the inhibitory receptor PD-1 results in a systemic decrease in tryptophan and tyrosine, which leads to a striking deficiency in the neurotransmitters serotonin and dopamine in the brain and anxiety-like behavior and exacerbated fear.

  • Subscribe to Nature Immunology for full access:

    $59

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    , & Cancer J. 21, 97–103 (2015).

  2. 2.

    & Natl. Rev. 5, 243–251 (2005).

  3. 3.

    et al. Nat. Immunol. 18, 1342–1352 (2017).

  4. 4.

    , & Annu. Rev. Immunol. 31, 259–283 (2013).

  5. 5.

    et al. Nat. Commun. 6, 6692 (2015).

  6. 6.

    et al. Immunity 45, 358–373 (2016).

  7. 7.

    Ann. NY Acad. Sci. 1129, 35–46 (2008).

  8. 8.

    et al. Transl. Psychiatry 2, e122 (2012).

  9. 9.

    et al. Nat. Immunol. 14, 500–508 (2013).

  10. 10.

    et al. J. Immunol. 185, 1037–1044 (2010).

  11. 11.

    et al. Immunity 40, 692–705 (2014).

  12. 12.

    , & Nat. Rev. Clin. Oncol. 8, 151–160 (2011).

Download references

Author information

Affiliations

  1. Laura Strauss, Nikolaos Patsoukis and Vassiliki A. Boussiotis are in the Division of Hematology-Oncology and Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

    • Laura Strauss
    • , Nikolaos Patsoukis
    •  & Vassiliki A Boussiotis

Authors

  1. Search for Laura Strauss in:

  2. Search for Nikolaos Patsoukis in:

  3. Search for Vassiliki A Boussiotis in:

Competing interests

V.A.B. holds patents on the PD-1 pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMDSerono, Boehringer Ingelheim, AstraZeneca, Novartis and Dako.

Corresponding author

Correspondence to Vassiliki A Boussiotis.

To obtain permission to re-use content from this article visit RightsLink.